(Q46705993)

24 December 2017

title

The P3 in 'ecstasy' polydrug users during response inhibition and execution (English)

1 reference

24 December 2017

author name string

Alex Gamma

1

1 reference

24 December 2017

Daniel Brandeis

2

1 reference

24 December 2017

Ruven Brandeis

3

1 reference

24 December 2017

Franz X Vollenweider

4

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

24 December 2017

Journal of Psychopharmacology

published in

1 reference

24 December 2017

volume

19

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

504-512

1 reference

24 December 2017

Questioning inhibitory control as the specific deficit of ADHD--evidence from brain electrical activity.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

What is inherited in the predisposition toward alcoholism? A proposed model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

A multiple source approach to the correction of eye artifacts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

The relative contributions of ecstasy and cannabis to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

21 January 2018

Varieties of impulsivity

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Electrophysiological measurements of anterior cingulate function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

A robust assessment of the NoGo-anteriorisation of P300 microstates in a cued Continuous Performance Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Serotonin transporter promoter polymorphism influences topography of inhibitory motor control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Electrophysiological signs of reduced prefrontal response control in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Mood state and brain electric activity in ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Reduced response-inhibition in obsessive-compulsive disorder measured with topographic evoked potential mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Developmental delay in P300 production in children at high risk for developing alcohol-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Reference-free identification of components of checkerboard-evoked multichannel potential fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Mental disorders in ecstasy users: a prospective-longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

The impact of regular ecstasy use on memory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

The scalp topography of potentials in auditory and visual Go/NoGo tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Effects of long-term cannabis use on selective attention: An event-related potential study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Differential impairments of selective attention due to frequency and duration of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Three-dimensional tomography of event-related potentials during response inhibition: evidence for phasic frontal lobe activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

The continuous performance test revisited with neuroelectric mapping: impaired orienting in children with attention deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

Probing the Time-Course of the Auditory Oddball P3 With Secondary Reaction Time

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056535

21 January 2018

Identifiers

DOI

10.1177/0269881105056535

1 reference

24 December 2017

PubMed ID

16166188

1 reference

24 December 2017